Get started
FLUOGUIDE A/SFLUOGUIDE A/SFLUOGUIDE A/S

FLUOGUIDE A/S

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

FLUO fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

FluoGuide A/S is a clinical stage biotechnology company, which engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent. Its technology includes uPAR, fluorescent guidance to surgical oncologists, and photothermal treatment. The company was founded by Andreas Kjaer on January 30, 2018 and is headquartered in Copenhagen, Denmark.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
FLUO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company